# PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteers

> **NCT04690426** · PHASE1 · COMPLETED · sponsor: **Provention Bio, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Viral; Infection, Coxsackie(Virus)

## Interventions

- **BIOLOGICAL:** PRV-101
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04690426
- **Lead sponsor:** Provention Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-14
- **Primary completion:** 2021-12-07
- **Final completion:** 2021-12-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04690426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04690426, "PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04690426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*